Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
cFLIP in the Molecular Regulation of Astroglia-Driven Neuroinflammation in Experimental Glaucoma
Author Affiliations & Notes
  • Gulgun Tezel
    Ophthalmology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States
  • Xiangjun Yang
    Ophthalmology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States
  • Qun Zeng
    Ophthalmology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States
  • Maide Gozde Inam
    Ophthalmology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States
  • Onur Inam
    Ophthalmology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States
  • Chyuan-Sheng Lin
    Pathology & Cell Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States
  • Footnotes
    Commercial Relationships   Gulgun Tezel None; Xiangjun Yang None; Qun Zeng None; Maide Inam None; Onur Inam None; Chyuan-Sheng Lin None
  • Footnotes
    Support  NIH Grants R01EY033359, P30EY019007, and RPB
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6776. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gulgun Tezel, Xiangjun Yang, Qun Zeng, Maide Gozde Inam, Onur Inam, Chyuan-Sheng Lin; cFLIP in the Molecular Regulation of Astroglia-Driven Neuroinflammation in Experimental Glaucoma. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6776.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recent studies of experimental glaucoma linked an anti-apoptotic molecule, cFLIP, to caspase-8-mediated cell type-specific death and inflammation pathways. To further test our related hypotheses, this study analyzed the outcomes of astroglia-targeted transgenic models of glaucoma.

Methods : We studied the mouse lines with conditional deletion of cFLIP or cFLIPL (also to determine isoform-specific differences) in astroglia (crossbreds of cFLIPf/f, cFLIPLf/f with GFAP-cre/ERT2) and background controls (cFLIPf/f, cFLIPLf/f). Glaucoma was modeled by anterior chamber microbead injections to induce ocular hypertension. Morphological analysis of astroglia assessed quantitative parameters using confocal microscopy images of the retinal whole-mounts immunolabeled for GFAP and inflammatory molecules or labeled for TUNNEL assay. The molecular analysis included 36-plexed immunoassays of cytokines and chemokines in the retina, NanoString-based profiling of inflammation-related gene expression and immunoblotting in freshly isolated samples of astroglia.

Results : Morphological analysis of the retina presented a >three-fold reduced production of the proinflammatory cytokine, TNF-α, in samples from GFAP/cFLIP and GFAP/FLIPL relative to controls at 12 weeks of ocular hypertension (n:4; P=0.002) with no detectable alteration in TUNNEL. Multiplex immunoassays of retinal proteins demonstrated >two-fold decrease in proinflammatory cytokines (including IL1, IL2, IFNγ, TNFα) and chemokines (including CCL4, 5, 7) in trangenic samples (P<0.01). Besides presenting a similar pattern of the proinflammatory versus anti-inflammatory molecules (P<0.01), NanoString-based molecular analysis detected decreased NF-κB/RelA (and phosphoRelA) and increased RelB (and phosphoRelB) expression of the astroglia in ocular hypertensive samples of GFAP/cFLIP and GFAP/cFLIPL compared to ocular hypertensive controls.

Conclusions : These findings value cFLIP in the molecular regulation of astroglia-driven neuroinflammation, as deletion of cFLIP or cFLIPL in astroglia modulates neurodegenerative inflammation in ocular hypertensive animals. This transgenic effect that should selectively affect proinflammatory/neurotoxic glial states primed for caspase-8/cFLIP interaction in TNFRs, TLRs, and inflammasome signaling does not shift the experimental paradigm to caspase-8-mediated cell death but alters transcriptional regulation of neuroinflammation.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×